Corbus Pharmaceuticals Holdings

Historical 13F Holders

Symbol
CRBP
CUSIP
21833P301
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 21833P301 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13G
9.9% 9/30/2026
Event 9/23/2026
MPM BioImpact LLC 13G 8.6% 11/13/2026
Event 9/30/2026
Cormorant Asset Management, LP 13G/A
7.8% 11/2/2026
Event 10/31/2026
BlackRock, Inc. 13G 5.9% 7/27/2026
Event 6/30/2026
OrbiMed Advisors LLC 13G/A
5.9% 2/14/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Vanguard Group Inc 13G/A 4.9% 7/29/2025
Event 6/30/2025
Citadel Advisors LLC 13G/A
1.1% 8/14/2026
Event 6/30/2026
Aberdeen Group plc 13G/A
0% 10/29/2026
Event 9/16/2026
Octagon Capital Advisors LP 13G/A
0% 5/14/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 124 17.6 M $120M
2026 Q2 107 13.8 M $129M
2026 Q1 108 12.9 M $121M
2025 Q4 102 13.3 M $108M
2025 Q3 88 8.80 M $109M
2025 Q2 83 9.07 M $62.5M
2025 Q1 88 10.4 M $55.4M
2024 Q4 101 11.0 M $129M
2024 Q3 112 11.8 M $243M
2024 Q2 108 10.8 M $486M
2024 Q1 85 8.53 M $335M
2023 Q4 36 750 k $4.53M
2023 Q3 29 743 k $5.00M
2023 Q2 30 739 k $5.80M
2023 Q1 31 724 k $5.26M
2020 Q1 1 1.00 k $5.24k
2019 Q4 1 1.00 k $5.46k